Recombinant Human Pyridoxal Kinase Protein, CF

R&D Systems | Catalog # 8658-PK

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human Pyridoxal Kinase Protein (8658-PK)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

O00764

Applications

Enzyme Activity
View all Pyridoxal Kinase/PDXK Proteins and Enzymes »

Product Specifications

Source

E. coli-derived human Pyridoxal Kinase/PDXK protein
Glu2-Leu312, with N-terminal Met and 6-His tag
Accession # O00764

Purity

>80%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

36 kDa

SDS-PAGE

36 kDa, reducing conditions

Activity

Measured by its ability to phosphorylate Pyridoxal Hydrochloride.
The specific activity is >85 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation, and Storage

8658-PK
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and DTT.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: Pyridoxal Kinase/PDXK

Pyridoxal Kinase (PDXK) phosphorylates vitamin B6, a step required for the conversion of vitamin B6 to pyridoxal-5-phosphate (PLP), an important cofactor in intermediary metabolism (1). PLP is involved in many aspects of macronutrient metabolism, neurotransmitter synthesis, histamine synthesis, as well as hemoglobin synthesis, function, and gene expression (2). PLP generally serves as a co-enzyme for many reactions and can help facilitate decarboxylation, transamination, racemization, elimination, replacement and beta-group inter-conversion reactions. In particular, PLP also is needed for the enzymatic reaction governing the release of glucose from glycogen. Overall, there are over 160 PLP-dependent enzymes, corresponding to ~4% of all known enzymatic activities (3). The classic clinical syndrome for B6 deficiency is a seborrhoeic dermatitis-like eruption, atrophic glossitis with ulceration, angular cheilitis, conjunctivitis, intertrigo, accompanied by neurologic symptoms of somnolence, confusion, and neuropathy (4).The neurotoxic effects of ophylline and ginkgotoxin are caused by their inhibitory activity against human PDXK (3, 5). Genetic variations of PDXK are associated with Parkinson disease, since PLP is involved in the biosynthesis of dopamine, a neurotransmitter linked to the disease characteristics such as motor and movement disorders (6). PDXK is also a potential drug target in the African trypanosomiasis (7). PDXK is a cytoplasmic enzyme and probably acts as a homodimer in vivo (8). The enzymatic activity of recombinant human CHKB is measured using a phosphatase-coupled method (9).

References

  1. Hanna, M.C. et al. (1997) J. Biol. Chem. 272:10756.
  2. Percudani R. and A. Peracchi (2003). EMBO Rep. 4: 850.
  3. Gandhi, AK et al. (2012) PLoS ONE. 7:e40954.
  4. Lichtstein, H.C. et al. (1945) J. Biol. Chem. 161:311.
  5. Kastner, U. et al. (2007) FEBS J. 274:1036.
  6. Vilarino-Guell, C. et al. (2010) Ann. Neurol. 67:409.
  7. Jones, D.C. et al. (2012) Mol. Microbiol. 86:51.
  8. Li, M.H. et al. (2002) J. Biol. Chem. 277:46385.
  9. Wu, Z.L. (2011) PLoS ONE 6:e23172.

Alternate Names

C21orf124, C21orf97, HEL-S-1a, PDXK, PKH, PNK, Vitamin B6 Kinase

Entrez Gene IDs

8566 (Human); 216134 (Mouse); 83578 (Rat)

Gene Symbol

PDXK

UniProt

O00764

Additional Pyridoxal Kinase/PDXK Products

Product Documents for Recombinant Human Pyridoxal Kinase Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human Pyridoxal Kinase Protein, CF

For research use only

Related Research Areas

Intracellular Kinases

Citations for Recombinant Human Pyridoxal Kinase Protein, CF

Customer Reviews for Recombinant Human Pyridoxal Kinase Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Pyridoxal Kinase Protein, CF and earn rewards!

Have you used Recombinant Human Pyridoxal Kinase Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Pyridoxal Kinase Protein, CF (8658-PK):

Materials
  • Universal Kinase Activity Kit (Catalog # EA004)
  • 10X Assay Buffer (supplied in kit): 250 mM HEPES, 1.5 M NaCl, 100 mM MgCl2, 100 mM CaCl2, pH 7.0
  • Recombinant Human Pyridoxal Kinase/PDXK (rhPDXK) (Catalog # 8658-PK)
  • ATP (supplied in kit): 10 mM
  • Pyridoxal Hydrochloride (Sigma, Catalog # P6155), 50 mM in deionized water
  • 96-well Clear Plate (Catalog # DY990)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Prepare 1X Assay Buffer by diluting 10X stock with deionized water.
  2. Dilute 1 mM Phosphate Standard supplied in the Universal Kinase Activity Kit by adding 40 µL of the 1 mM Phosphate Standard to 360 µL of 1X Assay Buffer for a 100 µM stock. This is the first point of the standard curve.
  3. Continue standard curve by performing six one-half serial dilutions of the 100 µM Phosphate stock in 1X Assay Buffer. The standard curve has a range of 0.078 to 5 nmol per well.
  4. Load 50 µL of each dilution of the standard curve into a plate. Include a curve blank containing 50 μL of 1X Assay Buffer.
  5. Prepare a reaction mixture containing 0.4 mM ATP and 2 mM Pyridoxal Hydrochloride in 1X Assay Buffer.
  6. Dilute Coupling Phosphatase 4 (supplied in kit) to 10 µg/mL in 1X Assay Buffer.
  7. Dilute rhPDXK to 133 µg/mL in 1X Assay Buffer.
  8. Load 15 µL of the 133 µg/mL rhPDXK into empty wells of the same plate as the curve. Include a control containing 15 µL of 1X Assay Buffer.
  9. Add 10 µL of 10 µg/mL Coupling Phosphatase 4 to wells containing enzyme and control, excluding the standard curve.
  10. Add 25 µL of reaction mixture to the wells, excluding the standard curve.
  11. Seal plate and incubate at room temperature for 10 minutes.
  12. Add 30 µL of the Malachite Green Reagent A to all wells.
  13. Add 100 µL of deionized water to all wells. Mix briefly.
  14. Add 30 µL of the Malachite Green Reagent B to all wells. Mix and incubate for 20 minutes at room temperature.
  15. Read plate at 620 nm (absorbance) in endpoint mode.
  16. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

 Phosphate released* (nmol) x (1000 pmol/nmol)
Incubation time (min) x amount of enzyme (µg) x coupling rate**

     
     *Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control
     **The coupling rate is 0.475 under these conditions.

Per Well:

  • rhPDXK:  2.0 µg
  • Coupling Phosphatase 4: 0.1 µg
  • ATP: 0.2 mM
  • Pyridoxal Hydrochloride:  1 mM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes